TDP-43 pathology occurs infrequently in multiple system atrophy

Neuropathol Appl Neurobiol. 2011 Jun;37(4):358-65. doi: 10.1111/j.1365-2990.2010.01136.x.

Abstract

Aims and methods: The α-synucleinopathy multiple system atrophy (MSA) and diseases defined by pathological 43-kDa transactive response DNA-binding protein (TDP-43) or fused in sarcoma (FUS) aggregates such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration show overlapping clinico-pathological features. Consequently, we examined MSA for evidence of TDP-43 or FUS pathology utilizing immunohistochemical studies in autopsy material from 29 MSA patients.

Results: TDP-43 pathology was generally rare, and there were no FUS lesions. The TDP-43 lesions were located predominantly in medio-temporal lobe and subcortical brain areas and were comprised mainly of dystrophic processes and perivascular (and subpial) lesions.

Conclusions: The multisystem clinical symptoms and signs of MSA, and in particular the neurobehavioural/cognitive and pyramidal features, appear not to result from concomitant TDP-43 or FUS pathology, but rather from widespread white matter α-synuclein positive glial cytoplasmic inclusions and neurodegeneration in keeping with a primary α-synuclein-mediated oligodendrogliopathy. The gliodegenerative disease MSA evidently results from different pathogenetic mechanisms than neurodegenerative diseases linked to pathological TDP-43.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Brain / metabolism
  • Brain / pathology*
  • DNA-Binding Proteins / metabolism
  • Female
  • Humans
  • Immunohistochemistry
  • Inclusion Bodies / metabolism
  • Inclusion Bodies / pathology*
  • Male
  • Middle Aged
  • Multiple System Atrophy / complications
  • Multiple System Atrophy / metabolism
  • Multiple System Atrophy / pathology*
  • RNA-Binding Protein FUS / metabolism
  • TDP-43 Proteinopathies / complications
  • TDP-43 Proteinopathies / metabolism
  • TDP-43 Proteinopathies / pathology*

Substances

  • DNA-Binding Proteins
  • RNA-Binding Protein FUS